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Aims and objectives
Giant cell arteritis (GCA) is the most frequent systemic vasculitis in middle-age and
elderly caucasian populations. Besides temporal arteries, the disease can mainly involve
the subclavian and axillary arteries and the aortic arch. The diagnosis of GCA may be
difficult due to clinical heterogeneity. The diagnostic hallmark of GCA is the presence of
inflammation in the vessel wall that can be effectively and reliably detected nowadays by
the noninvasive technique of Color Doppler ultrasonography (CDUS), as proved by many
clinical studies (1) . To the best of our knowledge no data exist about three dimensional
(3D) vascular ultrasound imaging in patients affected by GCA. We sought to assess the
extension of inflammatory involvement of temporal, subclavian and axillary arteries by
3D vascular ultrasound imaging in patients with confirmed or suspected GCA and to
evaluate the relations between inflammation markers abnormalities, clinical symptoms
and 3D findings.
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Methods and materials
Since January 2018 patients with confirmed or suspected GCA diagnosis were studied
with Siemens Paragon Sequoia, 9L4 4-9 MHz and Logiq9 4.5-16 MHz probes. GCA
diagnosis was made by rheumatologists according to clinical and laboratory parameters
(2-3) after instrumental confirmation by CDUS and/or PET examination (4). We set a
# 1mm diagnostic cut-off value for circumferential, hypoechogenic perivascular halo of
the temporal arteries and a # 1.5 mm hypoechogenic wall thickening for the axillary and
subclavian arteries (5-6). Clinical and laboratory data were collected. Discrete data are
summarized as frequencies while continuous as mean ± SD. #2 test or Fisher exact
test when appropriate were used for comparison of categorical variables. Analyses were
performed using the software package SPSS 19.
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Results
Twenty two patients were studied. Mean age was 70.4±12 years, 68% were women
(Figure 1). Among patients with confirmed GCA diagnosis, 54% had temporal arteritis,
while 27% had only subclavian and axillary involvement; among the remaining patients
(19%), referred to our centre for high clinical suspicion of GCA, one was affected
by systemic lupus erythematosus (SLE), two had polymyalgia rheumatica and one
rheumatoid arthritis. Most patients (94%) were on steroid treatment: 12% were on
steroids and tocilizumab and 18% on steroids plus methotrexate. At the time of 3D
vascular examination, 90% of patients complained at least one symptom: 60% headache,
17% fatigue, 20% fever, 42% polymyalgia, 5% visual loss, 45% jaw claudication (Figure
3). In most patients the inflammation markers were abnormal: erythrocyte sedimentation
rate (ESR) was increased in 64%, C reactive protein (CRP) in 66% and fibrinogen
in 72%. The halo sign was found in 62% of temporal arteries while a hypoechogenic
arterial wall thickening was demonstrated in 54% of axillary arteries and in 78% of
subclavian arteries. In only 6% of patients the halo sign involved only the main temporal
arteries. A multiple vessel inflammatory involvement was found in 36% of patients. In
all cases the 3D US examination confirmed the presence of inflammatory signs in both
cranial (temporal arteries) and extracranial (subclavian and axillary) vessels and it clearly
defined its inhomogenous and often spotty appearance (Figures 4-6), thus allowing, in
each arterial segment, a direct overall quantification of the inflammatory process. Jaw
claudication was the only symptom significantly associated with the detection of temporal
arteries halo sign (p=0.043). At the time of vascular examination the presence of at least
one symptom was significantly related with halo sign of temporal arteries (p=0.042).
Among the inflammatory markers only ESR and fibrinogen elevations were significantly
associated with the finding of halo sign of temporal arteries (p=0.015 and p=0.038,
respectively) but not with the detection of hypoechogenic wall thickening of subclavian
or axillary arteries (Figure 2).
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Images for this section:
Fig. 1: Table 1 describes the general patients characteristics.
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Fig. 2: Table 2. Clinical and laboratory findings associated with temporal arteries halo
sign.
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Fig. 3: Figure 3 describes the clinical symptoms of the study population
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Fig. 4: Figure 4 - 3D extended view of the hypoechogenic halo surrounding the main
temporal artery (A) and its parietal branch (B).
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Fig. 5: Figure 5 - Extended hypoechogenic inflammatory wall thickening of the left (A)
and right (B) subclavian arteries at 3D ultrasound examination.
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Fig. 6: Figure 6 - Extended hypoechogenic inflammatory wall thickening of the left (A)
and right (B) axillary arteries at 3D ultrasound examination.
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Conclusion
Three dimensional vascular ultrasound imaging can demonstrate even spotty
abnormalities along the entire vessel thus allowing a full extent detection and precise
estimate of the inflammatory process; these findings are especially useful for follow-
up purposes. Further studies will be nedeed to test reproducibility and interobserver
variability.
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